STOCK TITAN

Definium Therapeutics: Janus Henderson reports 5.4%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Definium Therapeutics, Inc. (DFTX) is the issuer of common shares for which Janus Henderson Group Ltd. reported beneficial ownership of 7,196,318 shares, or 5.4%, as of September 30, 2026. Janus reported shared voting and dispositive power over the shares and no sole voting or dispositive power. Its asset managers may be deemed beneficial owners through discretion exercised for client portfolios; those portfolios hold the rights to dividends and sale proceeds, and none owned more than 5% of DFTX's common shares.

Beneficially owned shares 7,196,318 shares Definium Therapeutics common shares; as of September 30, 2026
Ownership percentage 5.4% Of Definium Therapeutics common shares
Shared voting power 7,196,318 shares Common shares
Shared dispositive power 7,196,318 shares Common shares
Sole voting power 0 shares Common shares
Sole dispositive power 0 shares Common shares
beneficial owner regulatory
"may be deemed to be the beneficial owner of 7,196,318 common shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared power to vote regulatory
"Shared power to vote or to direct the vote"
dispositive power regulatory
"Shared Dispositive Power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Managed Portfolios financial
"collectively referred to herein as Managed Portfolios"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DFTX shares did Janus Henderson Group report beneficially owning?

Janus Henderson Group Ltd. reported beneficial ownership of 7,196,318 Definium Therapeutics common shares, or 5.4%, as of September 30, 2026. It reported shared voting and dispositive power over all 7,196,318 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





24477V105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP Ltd.
Signature:Kristin Mariani
Name/Title:Head of North America Compliance
Date:11/16/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Keep reading